0001104659-19-069438.txt : 20200108 0001104659-19-069438.hdr.sgml : 20200108 20191203150947 ACCESSION NUMBER: 0001104659-19-069438 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 2 FILED AS OF DATE: 20191203 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Arch Therapeutics, Inc. CENTRAL INDEX KEY: 0001537561 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 460524102 STATE OF INCORPORATION: NV FISCAL YEAR END: 0930 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: 235 WALNUT STREET, SUITE 6 CITY: FRAMINGHAM STATE: MA ZIP: 01702 BUSINESS PHONE: 617-431-2313 MAIL ADDRESS: STREET 1: 235 WALNUT STREET, SUITE 6 CITY: FRAMINGHAM STATE: MA ZIP: 01702 FORMER COMPANY: FORMER CONFORMED NAME: ALMAH,INC DATE OF NAME CHANGE: 20111216 CORRESP 1 filename1.htm

 

December 3, 2019

 

VIA EDGAR SUBMISSION

 

United States Securities and Exchange Commission

Division of Corporate Finance

100 F Street, N.E.

Washington, DC 20549

  

  Re: REQUEST FOR ACCELERATION OF EFFECTIVENESS
    Arch Therapeutics, Inc.
    Registration Statement on Form S-1
    File No. 333-234811

  

Ladies and Gentlemen:

 

Pursuant to Rule 461 of the Securities Act of 1933, as amended, Arch Therapeutics, Inc., a Nevada corporation (the “Company”), hereby respectfully requests that the effective date for the Registration Statement referred to above be accelerated so that it will be declared effective at 5:00 P.M., New York City time, on Thursday, December 5, 2019, or as soon thereafter as possible on such date.

 

Please provide a copy of the Commission’s order declaring the Registration Statement effective to the undersigned at 235 Walnut St., Suite 6, Framingham, MA 01702. Thank you for your assistance and cooperation.

 

Very truly yours,

Arch Therapeutics, Inc.

 

/s/ Richard E. Davis                              

Name: Richard E. Davis

Title: Chief Financial Officer

 

 

GRAPHIC 2 logo.jpg GRAPHIC begin 644 logo.jpg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end